Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Altimmune, Inc. | Chief Scientific Officer | Common Stock, par value $0.0001 | 43.3K | $234K | $5.41 | Jul 31, 2024 | Direct |
Altimmune, Inc. | Chief Scientific Officer | Common Stock, par value $0.0001 | 15 | $81.20 | $5.41 | Jul 31, 2024 | Shares held by spouse of Reporting Person |
Altimmune, Inc. | Chief Scientific Officer | Stock Options (option to buy) | 163K | Jan 25, 2024 | Direct | ||
Altimmune, Inc. | Chief Scientific Officer | Restricted Stock Units | 15.6K | Feb 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Jul 31, 2024 | 1 | $3.52K | 4 | Aug 1, 2024 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Feb 1, 2024 | 6 | -$39.5K | 4 | Feb 5, 2024 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jan 30, 2024 | 4 | -$10.8K | 4 | Feb 1, 2024 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jan 25, 2024 | 2 | $0 | 4 | Jan 29, 2024 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jul 31, 2023 | 1 | $1.6K | 4 | Aug 2, 2023 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Feb 2, 2023 | 3 | -$35.7K | 4 | Feb 6, 2023 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jan 31, 2023 | 4 | -$15.4K | 4 | Feb 2, 2023 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jul 31, 2022 | 1 | $5.02K | 4 | Aug 3, 2022 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jul 1, 2022 | 8 | -$365K | 4 | Jul 5, 2022 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jun 29, 2022 | 3 | -$51.3K | 4 | Jun 30, 2022 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jun 27, 2022 | 5 | -$369K | 4 | Jun 28, 2022 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jan 31, 2022 | 6 | -$2.97K | 4 | Feb 3, 2022 | Chief Scientific Officer |
ALT | Altimmune, Inc. | Jul 31, 2021 | 1 | $13.5K | 4 | Aug 6, 2021 | Chief Scientific Officer |